RavindraUppaluriMDPhD
Otolaryngology (ENT) • Boston, MAHead & Neck Oncologic Surgery
Director, Head and Neck Surgical Oncology, Chief, Division of Otolaryngology Dana-Farber Cancer Institute / Brigham and Women's Hospital
Dr. Uppaluri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
45 Francis Street
Boston, MA 02115Phone+1 617-525-3000- Is this information wrong?
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 1996 - 2001- Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 1996 - 2000
- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1995 - 1996
University of Minnesota Medical SchoolClass of 1995
Certifications & Licensure
MA State Medical License 2016 - 2024
MO State Medical License 1996 - 2017- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
- Fellow (FACS) American College of Surgeons
Clinical Trials
- GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer Start of enrollment: 2013 Feb 01
- Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer Start of enrollment: 2013 Jan 10
- Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma Start of enrollment: 2015 Mar 25
Publications & Presentations
PubMed
- IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS.Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang, Tatsuaki Daimon, Hiroki Ozawa, Keisuke Shigeta, Atsushi Fushimi, Nami Yamashit...> ;Cancer Research Communications. 2024 Apr 15
- Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer.Michihisa Kono, Shin Saito, Masahiro Rokugo, Ann Marie Egloff, Ravindra Uppaluri> ;Oral Oncology. 2024 May 1
- Patient Experience of Head and Neck Surgery With Free Flap Reconstruction.Lillian W Dattilo, Trinity I Russell, Chloe B Warinner, Heather Starmer, Donald J Annino Jr, Laura A Goguen, Rosh K V Sethi, Ravindra Uppaluri, Melina J Windon, Regan ...> ;JAMA Otolaryngology-- Head & Neck Surgery. 2024 Apr 1
- Join now to see all
Journal Articles
- A Deep Learning Approach to Automate Refinement of Somatic Variant Calling from Cancer Sequencing DataRavindra Uppaluri, Gavin P Dunn, Ramaswamy Govindan, S Joshua Swamidass, Todd A Fehniger, Nature
- Tumor Innate Immunity Primed by Specific Interferon-Stimulated Endogenous RetrovirusesScott Rodig, Ewa Sicinska, Thanh Uyen Barbie, David Allen Barbie, Russell William Jenkins, Ravindra Uppaluri, Rohit Thummalapalli, Jacob Sands, Nature
Press Mentions
In Situ Vaccination Following Intratumoral Injection of IL2 and Poly-L-lysine/Iron Oxide/CpG Nanoparticles to a Radiated Tumor SiteMay 22nd, 2023- Temporal Analysis of Type 1 Interferon Activation in Tumor Cells Following External Beam Radiotherapy or Targeted Radionuclide TherapyOctober 22nd, 2020
Study Adds Pembrolizumab to Paradigm for Certain Head and Neck CancersJuly 24th, 2015- Join now to see all
Grant Support
- IFN Gamma Induced Angiostatic ChemokinesNational Cancer Institute2002–2006
Professional Memberships
- Fellow
- Member
- Member
- Member
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
